graphic image of a lung scan with exaggerated cancer cells in the lungs

Two Phase 3 Trials Show New Treatment Paths for Different Non-Small Cell Lung Cancer Types

Selpercatinib lowers recurrence after surgery for RET fusion tumors; ivonescimab extends survival in advanced squamous disease

graphic of KRAS G12C mutation in non-small cell lung cancer (NSCLC)

New KRAS-Targeted Drugs Show Early Signals in Advanced Lung Cancer

Investigational therapies show tumor shrinkage in patients after standard treatments stop working

New Research Offers Hope for KRAS-Driven Lung Cancer

Study explores how blocking cancer’s survival pathway may improve responses in KRAS-mutant lung cancer

Medical Illustration showing lung cancer or bronchial carcinoma. 3d illustration

Triplet Therapy Shows Promise in Advanced Lung Cancer

EVOKE-02 study marks an innovative and unconventional approach

World Lung Cancer Day Spotlights Need for Critical Screenings

In 2022, only 4.5% of eligible Americans were screened for the disease

Landmark Lung Cancer Studies Set to Alter Standard of Care

New data reveals significant survival benefits for patients with stage 3 unresectable non-small cell and limited-stage small cell lung cancers

It has been five years since Kathryn VonAldenbruck was diagnosed with lung
cancer. She remains on an immunotherapy
regimen and continues to run.

Fighting Lung Cancer, One Step at a Time

Miles for Moffitt gives patients like Kathryn VonAldenbruck a chance to show they are thriving in the moment while raising money for the breakthroughs of tomorrow

Malnutrition Plays Role in Treatment Response, Study Shows

Lung cancer patients with recent weight loss had worse response to immunotherapy

Study Explores mRNA Vaccine Combo Therapy for Advanced Non-Small Cell Lung Cancer

Investigators study safety and efficacy of mRNA-based cancer vaccine combined with immunotherapy

Endeavor

Cambiar el idioma